Myriad ruling is a signal to the Supreme Court
11 August 2011
|
Eileen McDermott, New York
The Federal Circuit’s recent decision in the Myriad gene patent case could be a signal to the Supreme Court to take up the case, said one speaker during a webcast held yesterday
Professor Lawrence Sung of the University of Maryland School of Law and a partner at Dewey & LeBoeuf said that the Federal Circuit recognises its duty, as the exclusive appellate court for patent cases, to indicate to the High Court when there are unresolved issues highlighted by a particular case.
"What [the Federal Circuit] does at this stage is an important signalling mechanism to the Supreme Court," said Sung. "The Supreme Court often takes up cases on cert petition because there are divergent views among the regional circuits, and you simply will not have that dynamic with the CAFC. So a lot of the judges take it upon themselves to offer, not necessarily contradictory opinions, but opinions that go to the edges and various aspects of [the issues]."
In the Federal Circuit's...
Only subscribers have complete access to Managing IP,
log in or
subscribe now.
Alternatively take a
free trial, giving you seven days access to Managing IP and regular newsletters for the international IP community, and US and Canadian practitioners specifically.
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial